Alto Neuroscience ANRO Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's total liabilities & equity?
- Alto Neuroscience (ANRO) reported total liabilities & equity of $276.26M in Q1 2026.
- How has Alto Neuroscience's total liabilities & equity changed year-over-year?
- Alto Neuroscience's total liabilities & equity increased by 60.7% year-over-year, from $171.92M to $276.26M.
- What is the long-term trend for Alto Neuroscience's total liabilities & equity?
- Over 2 years (2023 to 2025), Alto Neuroscience's total liabilities & equity has grown at a 46.0% compound annual growth rate (CAGR), from $86.63M to $184.69M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.